Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3127798

[Cl-].[Cl-].c1ccc([Bi+2](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.33
APP P05067 1/20 0.39
ALDH1A1 P00352 4/20 0.38
TSHR P16473 5/20 0.35
TDP1 Q9NUW8 4/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
CA12 O43570 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA14 Q9ULX7 1/20 0.33
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33
NOTUM Q6P988 1/20 0.33
CA7 P43166 1/20 0.33
HSD17B10 Q99714 2/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL11576793 0.92 APP (0.39) APPALDH1A1TSHRTDP1CA1
Bromide SCHEMBL11573800 0.92 APP (0.39) APPALDH1A1TSHRTDP1CA1
Water SCHEMBL3133133 0.92 APP (0.39) APPALDH1A1TSHRTDP1CA1
Fluoride Ion SCHEMBL7529778 0.92 ALDH1A1 (0.39) APPALDH1A1TSHRTDP1CA1
SCHEMBL3127824 0.78 ALDH1A1 (0.48) ALDH1A1TSHRTDP1LMNAALOX12
Acetic Acid SCHEMBL17892007 0.74 HSD17B10 (0.44) ALDH1A1TSHRTDP1CA1CA2
Hydrochloric Acid SCHEMBL559968 0.73 KDM4E (0.40) ALDH1A1TDP1CA1CA2LMNA
Trichloroacetic Acid SCHEMBL23088971 0.69 CYP1A2 (0.40) ALDH1A1TSHRCA2GLACA4
Hydrochloric Acid SCHEMBL11884880 0.64
Phosphine SCHEMBL8521947 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116711732-B Application of triphenylbismuth dichloride in prevention and control of plant pathogenic fungi 华中农业大学 2025-06-10 CN claimed
CN-116711732-A Application of triphenylbismuth dichloride in prevention and control of plant pathogenic fungi 华中农业大学 2023-09-08 CN claimed
EP-3060536-B1 PROCESS FOR PRODUCING CHLORINATED HYDROCARBONS IN THE PRESENCE OF A POLYVALENT BISMUTH COMPOUND EAGLE US 2 LLC (US) 2018-07-18 EP claimed
EP-3060536-A1 PROCESS FOR PRODUCING CHLORINATED HYDROCARBONS IN THE PRESENCE OF A POLYVALENT BISMUTH COMPOUND Axiall Ohio, Inc. (US) 2016-08-31 EP claimed
US-9139497-B2 Process for producing chlorinated hydrocarbons in the presence of a polyvalent bismuth compound AXIALL OHIO, INC. (US) 2015-09-22 US claimed
WO-2015061067-A1 PROCESS FOR PRODUCING CHLORINATED HYDROCARBONS IN THE PRESENCE OF A POLYVALENT BISMUTH COMPOUND AXIALL OHIO, INC. (US) 2015-04-30 WO claimed
US-20150112104-A1 Process For Producing Chlorinated Hydrocarbons In The Presence Of A Polyvalent Bismuth Compound EAGLE US 2 LLC 2015-04-23 US claimed
US-8821906-B2 Biocompatible polymer GAMBRO LUNDIA AB (SE) 2014-09-02 US claimed
EP-1626750-B1 BIOCOMPATIBLE POLYMER GAMBRO LUNDIA AB (SE) 2010-07-21 EP claimed
US-20060275368-A1 Biocompatible polymer GAMBRO LUNDIA AB 2006-12-07 US claimed
JP-2006522172-A 2006-09-28 JP claimed
EP-1626750-A1 BIOCOMPATIBLE POLYMER Gambro Lundia AB (SE) 2006-02-22 EP claimed
WO-2004103425-A1 BIOCOMPATIBLE POLYMER GAMBRO LUNDIA AB (SE) 2004-12-02 WO claimed
US-12563861-B2 Photodiode element and sensor and electronic device SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-02-24 US disclosed
EP-4601438-A1 QUANTUM DOT LIGHT EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-08-13 EP disclosed
US-20250255089-A1 QUANTUM DOT LIGHT EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME AND ELECTRONIC DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2025-08-07 US disclosed
US-4479960-A 2,3,5,6-TETRAHYDRO-6-PHENYLIMIDAZO(2,1-B) THIAZOLE IN A DILUENT BAYER AG (DE) 1984-10-30 US disclosed
US-4414222-A TETRAMISOLE OR LEVAMISOLE WITH AN ALCOHOL OR ESTER BAYER AG (US) 1983-11-08 US disclosed
US-4336262-A Pour-on veterinary anthelmintic FISONS LTD. (GB) 1982-06-22 US disclosed
US-4113496-A ORGANIC SILVER SALT OXIDIZING AGENT, REDUCING AGENT, HALOGEN COMPO ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12563861-B2 Photodiode element and sensor and electronic device CRY1, CRY2, SLC9A2 ACHE 3319/4885APP 1936/4885ALDH1A1 1823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.